A combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals. The identified proteins could be used to tailor treatments to the individual based on the expected severity of the disease. The study, “Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis,” led by researchers at Linköping University in Sweden, has been published in the journal Nature Communications.
Health workers are experiencing ever-increasing levels of harassment and burnout in the wake of the pandemic, a new federal survey has found.
The American Red Cross has declared a national blood shortage emergency as donations plummet to the lowest levels seen in 20 years.
By NATION REPORTER
NATIONAL Union for Small-Scale Farmers in Zambia (NUSFAZ) says the unattractive pricing for other crops other than maize has discouraged small-scale farmers from embracing crop diversification.
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
It’s winter, that cozy season that brings crackling fireplaces, indoor gatherings—and a wave of respiratory illness. Nearly four years since the pandemic emerged, people are growing weary of dealing with it, but the virus is not done with us.
Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a study led by Nemours Children’s Health researchers and published in Cancer Research Communications.
By CINDY CHABALA
ECONOMIC expert Yusuf Dodia has urged Dr Situmbeko Musokotwane, the Minister of Finance and National Planning to provide an update on the progress of the Export Proceeds Tracking framework which was set to be implemented on January 1, 2024.
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
British drugmaker GlaxoSmithKline on Tuesday agreed to buy Aiolos Bio for up to $1.4 billion, with focus on an asthma medication still at the testing stage.
By BUUMBA CHIMBULU
ACCESS Bank Zambia Limited has finally completed its acquisition of Atlas Mara Zambia after obtaining all requisite regulatory approvals.
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
…returns to Lusaka to directly deal with the escalating cholera outbreak which has so far claimed 222 lives
“In view of the escalating Cholera situation, we are cutting short our holiday and return to Lusaka to provide more direct and frontline leadership in the fight against the outbreak,” President Hichilema announced in his short statement posted on his Facebook yesterday.
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.